Wells Fargo
PASG icon

Wells Fargo’s Passage Bio PASG Stock Holding History

Wells Fargo’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$903 Buy
+115
New +$1.19K ﹤0.01% 6347
2024
Q2 		– Sell
-15
Closed -$417 – 7317
2024
Q1 		$417 Hold
15
– – ﹤0.01% 6318
2023
Q4 		$307 Buy
15
+1
+7% +$14 ﹤0.01% 6497
2023
Q3 		$190 Buy
14
+2
+17% +$33 ﹤0.01% 6599
2023
Q2 		$230 Sell
12
-15
-56% -$297 ﹤0.01% 6659
2023
Q1 		$511 Buy
27
+15
+125% +$407 ﹤0.01% 6554
2022
Q4 		$317 Sell
12
-19
-61% -$479 ﹤0.01% 6498
2022
Q3 		$1K Sell
31
-1
-3% -$39 ﹤0.01% 6423
2022
Q2 		$2K Sell
32
-129
-80% -$6.03K ﹤0.01% 6352
2022
Q1 		$10K Sell
161
-662
-80% -$54.6K ﹤0.01% 6271
2021
Q4 		$105K Buy
823
+792
+2,555% +$129K ﹤0.01% 5604
2021
Q3 		$6K Buy
31
+7
+29% +$1.67K ﹤0.01% 6335
2021
Q2 		$6K Sell
24
-29
-55% -$8.97K ﹤0.01% 6292
2021
Q1 		$19K Sell
53
-433
-89% -$185K ﹤0.01% 6170
2020
Q4 		$248K Buy
486
+287
+144% +$115K ﹤0.01% 4971
2020
Q3 		$52K Sell
199
-147
-42% -$50.6K ﹤0.01% 5493
2020
Q2 		$189K Buy
+346
New +$156K ﹤0.01% 4942

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo's PASG Position: Q1 2026 in Review

Wells Fargo opened a new position in Passage Bio (PASG) in Q1 2026: 115 shares worth $903. The stake represents ﹤0.01% of the portfolio and ranks #6347 among its holdings. This is a return to the name: Wells Fargo previously reported a position in PASG as recently as Q1 2024.

Wells Fargo first reported a position in PASG in Q2 2020 and has held it in 17 quarters since. The position peaked at $248K in Q4 2020. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Wells Fargo held 115 shares of Passage Bio worth $903 as of Q1 2026.
  • Passage Bio was a new Wells Fargo position in Q1 2026.
  • Passage Bio made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6347 holding.
  • Wells Fargo first reported a position in Passage Bio in Q2 2020 and has held it in 17 quarters since.
  • Wells Fargo's Passage Bio position peaked at $248K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.